EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ALBI-SII grade: a novel prognostic indicator superior to Child–Pugh score for long-term survival in hepatocellular carcinoma and its nomogram construction and validation

Can Li, Xiaopeng Yu, Renyi Yang, Puhua Zeng

Frontiers in Oncology · 24.04.2026 · 16

DOI: 10.3389/fonc.2026.1781745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 24.04.2026. Verfasst von Can Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prognostic heterogeneity is common in patients with hepatocellular carcinoma (HCC) within the same clinical stage. While the albumin–bilirubin (ALBI) score and systemic immune-inflammation index (SII) have individual prognostic value, their combined significance remains unclear. We aimed to develop a novel ALBI-SII grade and a prognostic nomogram to refine risk stratification.

Methods

This retrospective study included 210 patients with HCC diagnosed between 2013 and 2021. A novel ALBI–SII grade was constructed by integrating ALBI and SII. Overall survival (OS) was analyzed using Kaplan–Meier methods and Cox regression based on a multiple imputation dataset. A nomogram incorporating ALBI–SII grade and China Liver Cancer (CNLC) staging was developed and validated using time-dependent ROC curves, DeLong’s test, and decision curve analysis (DCA).

Results

The ALBI–SII grade stratified patients into three distinct risk groups (Median OS: Grade 0, 639 days; Grade 1, 310 days; Grade 2, 148 days; P < 0.001). In multivariate analysis, ALBI-SII grade remained an independent prognostic factor (Grade 2 vs. 0: HR = 2.576, 95% CI: 1.654–4.012, P < 0.001). The 5-year AUC of ALBI-SII was 0.735, which was statistically comparable to that of CNLC staging (AUC = 0.724; DeLong’s P > 0.05). The nomogram demonstrated robust discrimination (C-index: 0.695) and favorable clinical net benefit.

Conclusion

The ALBI–SII grade is an objective and practical prognostic indicator for HCC. A nomogram integrating ALBI–SII and CNLC staging provides reliable survival prediction, particularly for long-term outcomes.

Schlagwörter

Stichwörter der Autor:innen

ALBI–SII gradehepatocellular carcinomanomogramprognosissystemic immune-inflammation index

Autor:innen und Institutionen

  • Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
  • Institute of Traditional Chinese Medicine Oncology, Hunan Academy of Chinese Medicine, Changsha, Hunan, China.

Zitieren

APA

Li, C., Yu, X., Yang, R., & Zeng, P. (2026). ALBI-SII grade: a novel prognostic indicator superior to Child–Pugh score for long-term survival in hepatocellular carcinoma and its nomogram construction and validation. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1781745

Vancouver

Li C, Yu X, Yang R, Zeng P. ALBI-SII grade: a novel prognostic indicator superior to Child–Pugh score for long-term survival in hepatocellular carcinoma and its nomogram construction and validation. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1781745

BibTeX
@article{Li2026,
  author = {Li, Can and Yu, Xiaopeng and Yang, Renyi and Zeng, Puhua},
  title = {ALBI-SII grade: a novel prognostic indicator superior to Child–Pugh score for long-term survival in hepatocellular carcinoma and its nomogram construction and validation},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1781745}
}
Kostenlos starten →